To: Ramsey Su who wrote (20268 ) 10/19/2004 1:05:36 PM From: russwinter Read Replies (4) | Respond to of 110194 Yes, apparently Spitzer is zeroing in on HMO related insurance issues, some massacres in names like AET: HMO shares plunge on worries over Spitzer probe Tue Oct 19, 2004 12:47 PM ET CHICAGO, Oct 19 (Reuters) - Cigna Corp. (CI.N: Quote, Profile, Research) on Tuesday said it received a new subpoena from the New York Attorney General in a broadening probe into conflicts between insurers and brokers, sending shares of the entire HMO sector down sharply. Cigna, one of the biggest U.S. health insurers, said New York Attorney General Eliot Spitzer requested more information about its dealings with brokers, following the company's disclosure of an inquiry in June. The Hartford Courant on Tuesday reported that Aetna also received an additional subpoena since June. Aetna did not return a call seeking comment. News of the requests came a week after Spitzer said he was suing the world's largest insurance broker, Marsh & McLennan (MMC.N: Quote, Profile, Research) , on charges of bid rigging at the cost of its clients, in an inquiry that implicated several other companies. New York Attorney General spokesman Marc Violette could not confirm that Spitzer issued new subpoenas. He did say Spitzer has said that the corrupt business practices likely are not limited to property and casualty insurers. "Traders are worried that the attorney general is going after the HMOs now," said Robert Mains, an analyst at Advest. Still, he noted that very big employers don't use brokers as a go-between with HMOs, like those targeted in the wider Spitzer probe. The brokers are commonly used among companies with 500 or less employees, according to Ed Kaplan, a health policy expert at the Segal Co., which consults on benefits issues for employers. Shares of Aetna were off $12.44, or 12.7 percent, to $85.30; shares of UnitedHealth Group. (UNH.N: Quote, Profile, Research) were off $6.42, or 8.8 percent, to $66.93; Humana (HUM.N: Quote, Profile, Research) shares were down $1.44, or 7.5 percent, to $17.76; while those of Cigna were down $6.99, or 10.5 percent, to $59.59, all on the New York Stock Exchange.